• 1. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
• 2. Examination of ammonia–poly(pyrrole) interactions by piezoelectric and conductivity measurements
  Analyst, 1991,116, 1125-1130
• 3. Fast-Track to Research Data Management in Experimental Material Science-Setting the Ground for Research Group Level Materials Digitalization.
  LarsBanko,AlfredLudwig
• 4. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 5. Establishing new scaling relations on two-dimensional MXenes for CO2 electroreduction?
  Albertus D. Handoko,Khoong Hong Khoo,Teck Leong Tan,Hongmei Jin,Zhi Wei Seh J. Mater. Chem. A, 2018,6, 21885-21890

Methyl 6-bromoimidazo[1,2-a]pyridine-2-carboxylate (CAS No. 354548-08-6): A Versatile Building Block in Modern Pharmaceutical Chemistry

Methyl 6-bromoimidazo[1,2-a]pyridine-2-carboxylate (CAS No. 354548-08-6) is a highly valuable intermediate in the field of pharmaceutical chemistry, serving as a critical building block for the synthesis of various bioactive molecules. This compound, characterized by its imidazo[1,2-a]pyridine core structure, has garnered significant attention due to its utility in the development of novel therapeutic agents. The presence of a bromine substituent at the 6-position enhances its reactivity, making it an attractive scaffold for further functionalization through cross-coupling reactions and other chemical transformations.

The imidazo[1,2-a]pyridine scaffold is a privileged structure in medicinal chemistry, known for its broad biological activity and favorable pharmacokinetic properties. Compounds containing this moiety have been extensively studied for their potential applications in treating various diseases, including cancer, infectious diseases, and inflammatory disorders. The carboxylate ester group in Methyl 6-bromoimidazo[1,2-a]pyridine-2-carboxylate provides an additional handle for chemical modification, allowing for the introduction of diverse functional groups and the optimization of drug-like properties.

Recent advancements in synthetic methodologies have further highlighted the importance of this compound. For instance, palladium-catalyzed cross-coupling reactions, such as Suzuki-Miyaura and Buchwald-Hartwig couplings, have been widely employed to introduce aryl or heteroaryl groups at the brominated position. These reactions not only expand the structural diversity of derivatives but also enhance their biological activity. Moreover, the carboxylate ester can be readily converted into other functional groups, such as carboxylic acids or amides, through hydrolysis or amidation reactions.

In the realm of drug discovery, Methyl 6-bromoimidazo[1,2-a]pyridine-2-carboxylate has been utilized in the synthesis of several lead compounds that exhibit promising pharmacological effects. For example, derivatives of this scaffold have shown inhibitory activity against kinases and other enzymes implicated in cancer progression. The bromine atom serves as a versatile handle for further derivatization, enabling the exploration of novel chemical space and the identification of more potent and selective inhibitors.

The compound's utility extends beyond oncology. Researchers have also explored its potential in treating infectious diseases caused by bacterial and viral pathogens. By leveraging its reactivity and structural features, scientists have designed molecules that target essential pathways in pathogens while minimizing toxicity to host cells. This approach aligns with the growing need for innovative strategies to combat antibiotic resistance and emerging infectious diseases.

The synthesis of Methyl 6-bromoimidazo[1,2-a]pyridine-2-carboxylate itself is a testament to the progress in organic synthesis techniques. Modern methods allow for efficient and scalable production of this intermediate, ensuring that it remains readily available for use in research and industrial settings. The optimization of synthetic routes has not only improved yield but also reduced environmental impact through greener chemistry principles.

As our understanding of biological systems continues to evolve, so does the demand for sophisticated molecular tools like Methyl 6-bromoimidazo[1,2-a]pyridine-2-carboxylate. Its versatility makes it an indispensable tool for chemists and biologists working at the intersection of chemistry and biology. By providing a robust platform for drug discovery and molecular innovation, this compound plays a pivotal role in advancing therapeutic interventions across multiple disease areas.

The future prospects for this compound are promising. Ongoing research aims to uncover new synthetic strategies that further enhance its utility and expand its applications. Collaborative efforts between academia and industry are expected to yield novel derivatives with enhanced efficacy and improved safety profiles. As such, Methyl 6-bromoimidazo[1,2-a]pyridine-2-carboxylate will continue to be a cornerstone in pharmaceutical research and development.

• 67625-37-0(Ethyl 6-bromoimidazo[1,2-a]pyridine-2-carboxylate)
• 847446-55-3(Ethyl 8-Bromo-6-methylimidazo1,2-apyridine-2-carboxylate)
• 725234-40-2(6-Bromoimidazo[1,2-a]pyridine-2-carboxylic acid hydrobromide)
• 81438-56-4(Ethyl 6-Bromo-2-Methylimidazo1,2-APyridine-3-Carboxylate)
• 1187236-18-5(Ethyl 7-bromoimidazo[1,2-a]pyridine-2-carboxylate)
• 135995-45-8(Ethyl 8-bromo-5-methylimidazo1,2-apyridine-2-carboxylate)
• 944896-42-8(6-Bromoimidazo[1,2-a]pyridine-3-carboxylic acid)
• 1038393-19-9(ethyl 8-bromoimidazo[1,2-a]pyridine-2-carboxylate)
• 749849-14-7(6-Bromoimidazo[1,2-a]pyridine-2-carboxylic acid)
• 372198-69-1(Ethyl 6-bromoimidazo[1,2-a]pyridine-3-carboxylate)